Aug 21,2019

BD to Present at Investor Healthcare Conferences

Live webcasts of BD's presentations can be accessed on the BD corporate website at www.bd.com/investors. They will be available for replay for a period of seven days after each conference.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Aug 22,2019

DIAMONTECH'S FIRST PRODUCT 'DMT BASE' RECEIVES CE CERTIFICATION FOR NON-INVASIVE BLOOD GLUCOSE MEASUREMENT USING LASER-BASED TECHNOLOGY

DiaMonTech GmbH, a young medical technology company, has received CE certification for its first medical product "DMT Base". The device enables non-invasive blood glucose measurement using laser-based technology. The certification confirms that the patented technology meets the high safety and performance standards for medical devices required for market approval. The marking applies to all countries of the European Union.

REGULATORY FDA

#bgm

View Analyst & Ambassador Comments
Go to original news
Aug 28,2019

DarioHealth to Present at RHK Capital Disruptive Growth Conference on Thursday, September 5th

Leading global digital therapeutics company DarioHealth Corp. today announced that DarioHealth's Chief Executive Officer, Erez Raphael, will present to and meet with investors and analysts attending the RHK Capital Disruptive Growth Conference on Thursday, September 5, 2019 in New York City.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Aug 29,2019

Tandem Diabetes Care Announces Upcoming Conference Participation and Presentations

The Company update presentations will be webcast live, and an archive recording will be available for 30 days. The link to the live webcast and archive will be accessible on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Sep 04,2019

Liva Healthcare wins EU funding to help pregnant women at risk of Type 2 diabetes

Liva Healthcare has secured €603,405 in funding from the EU Horizon 2020 programmes to be part of the "Impact Diabetes Bump 2 Baby" (IDB2B) research project. The digital health coaching app, headquartered in London and Copenhagen, will work toward finding the best way to treat mothers at risk of developing Type 2 diabetes.

FUNDING GRANT
View Analyst & Ambassador Comments
Go to original news
Sep 30,2019

Fitbit and Health2Sync collaborate to support diabetes management in Taiwan and Japan

Fitbit and Taiwan-based diabetes management app Health2Sync announced last week that Fitbit health, sleep and fitness data can now be integrated with the Health2Sync app to support Health2Sync’s 360,000 users in Taiwan and Japan to better manage their diabetes.

COLLABORATION PARTNERSHIP

#connected device

#mobile app

View Analyst & Ambassador Comments
Go to original news
Sep 30,2019

BioCrossroads announces DataX BioInnovation Challenge

As a way to foster artificial intelligence and machine learning as key tools to realizing new discoveries in the life sciences, BioCrossroads announced a new competition where innovators can use data sets to identify and investigate a hypothesis aimed at improving two Indiana health issues – diabetes and opioid abuse. The BioCrossroads DataX BioInnovation Challenge was created to intersect life sciences and data research and encourage new ways of investigating traditional disease biology and public health outcomes’ questions. Founded on the premise that asking critical questions can leverage and bridge publicly available data sets, the Challenge seeks to foster new solutions and innovation.

View Analyst & Ambassador Comments
Go to original news
Feb 19,2021

MyWay Digital Health eLearning Courses Win Highly Commended at the BMA Patient Information Awards 2019

MyWay Digital Health currently have 6 QISMET accredited diabetes courses that are available for patients.

View Analyst & Ambassador Comments
Go to original news
Feb 19,2021

MyWay Digital Health chosen as Sandbox exemplar by HDRUK to improve AI in diabetes care

HDRUK has set up data hubs across the UK that will be at the forefront of health data research that will facilitate new health discoveries and give patients access to pioneering health treatments.

View Analyst & Ambassador Comments
Go to original news
Sep 03,2019

Actiste – world’s first unified IoT diabetes care device – has received market approval (CE mark).

Actiste®, the world’s first unified diabetes care device with eSIM technology for monitoring and treating insulin-dependent diabetes, has received not only one, but two, EC certificates (CE marks) from TÜV Rheinland (Notified Body).

REGULATORY CE MARK

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES